Trials / Withdrawn
WithdrawnNCT02517671
Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- David Grant U.S. Air Force Medical Center · Federal
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the effects of 35 EECP sessions on cardiopulmonary training performance in healthy volunteers. Data from this study will be used to generate sample size and power calculations for feasibility of future EECP studies. The results of this study could provide evidence that can help active duty and Department of Defense beneficiaries optimize physical conditioning, endurance and overall health.
Detailed description
The purpose of this study is to assess the effects of 35 EECP sessions on cardiopulmonary training performance in healthy volunteers. Prior published and anecdotal evidence suggests that EECP should improve athletic performance. Data from this study will be used to generate sample size and power calculations for feasibility of future EECP studies. The results of this study could provide evidence that can help active duty and Department of Defense beneficiaries optimize physical conditioning, endurance and overall health. It could help active duty members maximize their physical training potential enabling them to better prepare for missions down range. Additionally, physiologic cardiopulmonary improvements may have the potential to decrease the conditioning time required for injured, post-operative and post-partum active duty members to return to duty.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Enhanced External Counterpulsation (EECP) | EECP is a non-invasive therapy that has been approved by the United States Food and Drug Administration (FDA) for the management of refractory angina and heart failure. This study is using the device to potentially improve 1.5 mile run times and VO2max in healthy volunteers. |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2017-10-07
- Completion
- 2017-10-07
- First posted
- 2015-08-07
- Last updated
- 2018-03-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02517671. Inclusion in this directory is not an endorsement.